www.senology.org

 Newsletter

"Join  the senologic and oncologic  scientific community"

Gian Paolo Andreoletti, MD, Editor-in-Chief  -  paolo.andreoletti@senology.it

 Educational Grants - Sincere appreciation is extended to the following companies for their generous support of this activity:

     

Subscribe     Unsubscribe     Contact     Back Issues     www.senology.org Home Page

Best Study of the Month

Vote for your favourite study

Literature Selection

Comment

  • "Systemic inflammation may affect breast epithelial cancer"  - James Goedert, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
     
    "The importance of inflammation and immunity on the development of breast cancer is unclear. Breast cancer risk appears to be somewhat lower in women who use nonsteroidal anti-inflammatory drugs (NSAIDs) or who have rheumatoid arthritis (RA). However, breast cancer risk with other systemic autoimmune rheumatic diseases (SARDs) and particularly by estrogen receptor (ER) status is unknown. In 84,778 women in the American population age 67-99 who developed breast cancer and an equal number of women who did not develop breast cancer, we compared the prevalence of RA and other SARDs. The risk of breast cancer, both ER-positive and ER-negative, was significantly reduced 13% among women with RA.  ER-negative, but not ER-positive, breast cancer also was lower among women with systemic lupus erythematosus (SLE). Other SARDs, most of which are treated with NSAIDs, were unrelated to breast cancer risk. This suggests that alterations of immunity with RA, and perhaps with SLE, reduce the risk of breast cancer among older women. However, the reduction in risk is small with RA, so women with SARDs should still adhere to mammographic screening to assure that breast cancers are detected early and treated effectively"
    (Comment on: Gadalla SM et al.: "Breast cancer risk in elderly women with systemic autoimmune rheumatic diseases: a population-based case-control study", Br J Cancer. 2009; 100(5):817-21)

Press Releases

Images

Invasive lobular carcinoma

Stefano Ciatto, - CSPO - Istituto Scientifico Prevenzione Oncologica, Florence, Italy

Submit an image

Calendar of Events

 

Best Study of the Month

Vote for your favourite study

Literature Selection

Press Releases

Clinical Guidelines

 


Literature Selection

Stay informed....

Recent Advances in Clinical Medicine

If this e-mail has reached you in error, simply click on the following link and unsubscribe yourself Unsubscribe

Contact info - For advertising information please contact: A&B@senology.it . For other enquiries, problems or suggestions please contact: staff@senology.it

A&B Edizioni Medico-Scientifiche - Milan,  Italy.  Fax: +39.035.738803

     

www.senology.org